Clinical Relevance and Advantages of Intradermal Test Results in 371 Patients with Allergic Rhinitis, Asthma and/or Otitis Media with Effusion

Background: We evaluated the value of positive intradermal dilution testing (IDT) after negative skin prick tests (SPT) by retrospectively determining allergy immunotherapy (AIT) outcomes. Methods: This private practice, cohort study compared the relative value of SPT vs. IDT in 371 adults and child...

Full description

Bibliographic Details
Main Authors: David S. Hurst, Alan B. McDaniel
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/11/3224
_version_ 1797510821546295296
author David S. Hurst
Alan B. McDaniel
author_facet David S. Hurst
Alan B. McDaniel
author_sort David S. Hurst
collection DOAJ
description Background: We evaluated the value of positive intradermal dilution testing (IDT) after negative skin prick tests (SPT) by retrospectively determining allergy immunotherapy (AIT) outcomes. Methods: This private practice, cohort study compared the relative value of SPT vs. IDT in 371 adults and children with suspected manifestations of allergy: chronic allergic rhinitis (AR), asthma and/or chronic otitis media with effusion (OME). The primary outcome measure was symptom resolution following immunotherapy, as determined by symptom severity questionnaires completed by patients before and after AIT. Results: Positive IDT identified 193 (52%) patients who would not otherwise have been diagnosed. IDT detected 3.7-fold more allergens per patient than SPT (8.56 vs. 2.3; <i>p</i> < 0.01). Patients positive only on IDT responded to AIT equally well as those identifiable by SPT, independent of allergen sensitivity (67% by SPT vs. 62% by IDT; <i>p</i> = 0.69, not significantly different). Conclusion: Intradermal titration can identify patients who will benefit from allergy immunotherapy more accurately than SPT. Outcomes analysis in 371 patients shows that IDT doubled their chance of successful treatment with no greater risk of therapeutic failure. Positive IDT, following negative SPT, is clinically relevant and offers superior sensitivity over SPT for detecting allergens clinically relevant to diagnosis of AIT-responsive atopic disease.
first_indexed 2024-03-10T05:36:43Z
format Article
id doaj.art-c88b3aa75eec40a3bcfba00273361e7f
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T05:36:43Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-c88b3aa75eec40a3bcfba00273361e7f2023-11-22T22:53:07ZengMDPI AGCells2073-44092021-11-011011322410.3390/cells10113224Clinical Relevance and Advantages of Intradermal Test Results in 371 Patients with Allergic Rhinitis, Asthma and/or Otitis Media with EffusionDavid S. Hurst0Alan B. McDaniel1Department of Otolaryngology, Tufts University, Boston, MA 02111, USADepartment of Otolaryngology, University of Louisville, Louisville, KY 40202, USABackground: We evaluated the value of positive intradermal dilution testing (IDT) after negative skin prick tests (SPT) by retrospectively determining allergy immunotherapy (AIT) outcomes. Methods: This private practice, cohort study compared the relative value of SPT vs. IDT in 371 adults and children with suspected manifestations of allergy: chronic allergic rhinitis (AR), asthma and/or chronic otitis media with effusion (OME). The primary outcome measure was symptom resolution following immunotherapy, as determined by symptom severity questionnaires completed by patients before and after AIT. Results: Positive IDT identified 193 (52%) patients who would not otherwise have been diagnosed. IDT detected 3.7-fold more allergens per patient than SPT (8.56 vs. 2.3; <i>p</i> < 0.01). Patients positive only on IDT responded to AIT equally well as those identifiable by SPT, independent of allergen sensitivity (67% by SPT vs. 62% by IDT; <i>p</i> = 0.69, not significantly different). Conclusion: Intradermal titration can identify patients who will benefit from allergy immunotherapy more accurately than SPT. Outcomes analysis in 371 patients shows that IDT doubled their chance of successful treatment with no greater risk of therapeutic failure. Positive IDT, following negative SPT, is clinically relevant and offers superior sensitivity over SPT for detecting allergens clinically relevant to diagnosis of AIT-responsive atopic disease.https://www.mdpi.com/2073-4409/10/11/3224allergic rhinitisallergensallergy immunotherapyasthmaotitis mediasinusitis
spellingShingle David S. Hurst
Alan B. McDaniel
Clinical Relevance and Advantages of Intradermal Test Results in 371 Patients with Allergic Rhinitis, Asthma and/or Otitis Media with Effusion
Cells
allergic rhinitis
allergens
allergy immunotherapy
asthma
otitis media
sinusitis
title Clinical Relevance and Advantages of Intradermal Test Results in 371 Patients with Allergic Rhinitis, Asthma and/or Otitis Media with Effusion
title_full Clinical Relevance and Advantages of Intradermal Test Results in 371 Patients with Allergic Rhinitis, Asthma and/or Otitis Media with Effusion
title_fullStr Clinical Relevance and Advantages of Intradermal Test Results in 371 Patients with Allergic Rhinitis, Asthma and/or Otitis Media with Effusion
title_full_unstemmed Clinical Relevance and Advantages of Intradermal Test Results in 371 Patients with Allergic Rhinitis, Asthma and/or Otitis Media with Effusion
title_short Clinical Relevance and Advantages of Intradermal Test Results in 371 Patients with Allergic Rhinitis, Asthma and/or Otitis Media with Effusion
title_sort clinical relevance and advantages of intradermal test results in 371 patients with allergic rhinitis asthma and or otitis media with effusion
topic allergic rhinitis
allergens
allergy immunotherapy
asthma
otitis media
sinusitis
url https://www.mdpi.com/2073-4409/10/11/3224
work_keys_str_mv AT davidshurst clinicalrelevanceandadvantagesofintradermaltestresultsin371patientswithallergicrhinitisasthmaandorotitismediawitheffusion
AT alanbmcdaniel clinicalrelevanceandadvantagesofintradermaltestresultsin371patientswithallergicrhinitisasthmaandorotitismediawitheffusion